Inspire Medical $75 million Accelerated Share Repurchase Program

  Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company’s common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company’s Board of Directors.

https://www.globenewswire.com/news-release/2024/11/11/2978173/0/en/Inspire-Medical-Systems-Inc-Announces-75-million-Accelerated-Share-Repurchase-Program.html